The Dow Jones Industrial Average is climbing Friday afternoon with shares of Walmart and Amgen seeing positive gains for the price-weighted average.

Amgen's Nplate proves highly effective in preventing thrombocytopenia from chemotherapy, enabling full-dose cancer treatment ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

GTS Securities sliced its Amgen stake by over half, dumping 6,541 shares and leaving just 5,117 shares worth $1.3 million.

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

Alan Berro of American Funds Washington Mutual focuses on buying good companies at a decent price, such as Amgen, Comcast, ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.